awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37637905-3EF28F54-3FDB-40D1-94FE-F9E7A6DC678F
Q37637905-3EF28F54-3FDB-40D1-94FE-F9E7A6DC678F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37637905-3EF28F54-3FDB-40D1-94FE-F9E7A6DC678F
Second-Line Treatment of NSCLC-The Pan-ErbB Inhibitor Afatinib in Times of Shifting Paradigms.
P2860
Q37637905-3EF28F54-3FDB-40D1-94FE-F9E7A6DC678F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37637905-3EF28F54-3FDB-40D1-94FE-F9E7A6DC678F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a42f17d44dc0b47e6cc4513a98bb7201252b8e12
P2860
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.